Ligand Pharmaceuticals
LGND
#2843
Rank
A$8.69 B
Marketcap
A$433.85
Share price
2.34%
Change (1 day)
100.20%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$0.24 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.26 Billion. , an increase over its 2024 earnings that were of A$7.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.23 B2848.57%
2024 A$7.93 M-91.37%
2023 A$91.97 M-7.59%
2022 A$99.52 M4%
2021 A$95.69 M296.42%
2020 A$24.14 M-97.97%
2019 A$1.19 B275.62%
2018 A$0.31 B237.48%
2017 A$93.89 M49.05%
2016 A$62.99 M55.41%
2015 A$40.53 M36.87%
2014 A$29.61 M29.59%
2013 A$22.85 M1309.35%
2012 A$1.62 M-43.97%
2011 A$2.89 M-113.19%
2010 -A$21.95 Million59.86%
2009 -A$13.73 Million-61.33%
2008 -A$35.5 Million-58.75%
2007 -A$86.06 Million20.52%
2006 -A$71.4 Million81.27%
2005 -A$39.39 Million
2003 -A$27.43 Million-20.6%
2002 -A$34.54 Million4.38%
2001 -A$33.09 Million-48.83%
2000 -A$64.66 Million-19.74%
1999 -A$80.56 Million-19.06%
1998 -A$99.53 Million126.71%
1997 -A$43.91 Million-5.83%
1996 -A$46.62 Million136.23%
1995 -A$19.74 Million-33.97%
1994 -A$29.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.14 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.14 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.50 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.99 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.73 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.80 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.72 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.31 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$88.49 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA